Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4869683 | 0.94 | TRPV1 (0.82) | TRPV1 | |
| SCHEMBL4868027 | 0.92 | TRPV1 (1.00) | TRPV1 | |
| SCHEMBL4871707 | 0.91 | TRPV1 (0.78) | TRPV1 | |
| SCHEMBL4874196 | 0.90 | TRPV1 (0.84) | TRPV1 | |
| SCHEMBL4869732 | 0.90 | TRPV1 (0.84) | TRPV1 | |
| SCHEMBL4873173 | 0.90 | TRPV1 (0.84) | TRPV1 | |
| SCHEMBL12910256 | 0.89 | TRPV1 (0.75) | TRPV1MALT1 | |
| SCHEMBL4873167 | 0.88 | TRPV1 (0.81) | TRPV1 | |
| SCHEMBL10323906 | 0.88 | TRPV1 (0.81) | TRPV1 | |
| SCHEMBL4869481 | 0.87 | TRPV1 (0.79) | TRPV1MALT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8168827-B2 | Amide derivative | AJINOMOTO CO., INC. (JP) | 2012-05-01 | — | — | US | disclosed |
| US-20090258900-A1 | AMIDE DERIVATIVE | AJINOMOTO CO. INC (JP) | 2009-10-15 | — | — | US | disclosed |
| US-7572815-B2 | Amide derivative | AJINOMOTO CO., INC. (JP) | 2009-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090258900-A1 | AMIDE DERIVATIVE | NR0B1, NR0B2, NR1I3 | TRPV1 804/4885MALT1 2829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.